06:46 AM EDT, 10/29/2025 (MT Newswires) -- United Therapeutics ( UTHR ) reported Q3 net income Wednesday of $7.16 per diluted share, up from $6.39 a year earlier.
Analysts polled by FactSet expected $7.32.
Revenue for the quarter ended Sept. 30 was $799.5 million, compared with $748.9 million a year earlier.
Analysts surveyed by FactSet expected $812.8 million.